Communications with Shareholders

RNS Number : 9955K
Arix Bioscience Plc
12 May 2022
 

12 May 2022

 

ARIX BIOSCIENCE PLC (the "Company")

Electronic Communication with Shareholders

 

The Company is pleased to announce it has today posted a letter to all Shareholders (the "Letter") requesting their individual consent to the use of electronic means of communication and in that regard choose from three options. 

 

The Letter is also available on the Company's website:

https://arixbioscience.com/investor-relations/document-library

 

 

Enquiries:

Email:  ir@arixbioscience.com

LEI:    213800OVT3AHQCXNIX43

 

Registrar and Receiving Agent:   Equiniti Limited - 0371 384 2030 or +44 121 415 7047

Company Secretary: Kin Company Secretarial Limited - +44 20 8819 6486

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCURSSRUNUVAAR

Companies

Arix Bioscience (ARIX)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today